Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Coursera Inc (COUR) vs Medpace Holdings Inc (MEDP) Price & Performance

Coursera IncTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Coursera Inc vs Medpace Holdings Inc — how do they compare? Coursera Inc trades at $5.56 (market cap $1.50B), while Medpace Holdings Inc trades at $599.77 (market cap $16.90B). The key difference: Medpace Holdings Inc is far larger — about 11.3× Coursera Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Coursera Inc nearer its low. Which is the better fit depends on your goals.

COURMEDP
Market Cap
$1.50B$16.90B
Sector
Consumer StaplesTechnology
52-Week High
$12.20$620.59
52-Week Low
$5.09$393.42
Enterprise Value
$759.54M$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Coursera Inc

Coursera (COUR) trades at $5.525, down 4.08% today, with a bearish technical signal from moving averages. Revenue grew to $757.5M in 2025, but net losses persist at -$51M. Recent Q2 2026 earnings beat expectations at $0.17 EPS, and the company made a $100M strategic investment in AI education firm LearnVector (Business Wire, July 28, 2026).

The stock offers upside to the $7.70 consensus price target, supported by a majority buy rating from analysts. However, profitability challenges and competitive pressures in online education pose risks. Positive cash flow trends and institutional interest provide a foundation for recovery if execution improves.

Medpace Holdings Inc

MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.

Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Coursera Inc

Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.

Read more on COUR

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP